ProfileGDS4718 / 205055_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 91% 94% 90% 90% 92% 93% 91% 90% 91% 91% 93% 92% 93% 94% 91% 91% 93% 95% 92% 91% 91% 91% 92% 91% 90% 89% 94% 91% 90% 92% 92% 91% 91% 90% 93% 91% 93% 91% 94% 92% 92% 93% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6849992
GSM549102patient 115, normal, homogenized [OPG study]9.4085191
GSM549104patient 119, normal, homogenized [OPG study]9.9320294
GSM549108patient 138, normal, homogenized [OPG study]9.2099190
GSM549119patient 077, normal, homogenized [OPG study]9.1848990
GSM549133patient 032, cancer, homogenized [OPG study]9.6596892
GSM549139patient 042, cancer, homogenized [OPG study]9.7549793
GSM549099patient 107, normal, homogenized [OPG study]9.4133391
GSM549109patient 139, normal, homogenized [OPG study]9.2555690
GSM549110patient 046, normal, homogenized [OPG study]9.3470591
GSM549114patient 063, normal, homogenized [OPG study]9.6185391
GSM549122patient 082, normal, homogenized [OPG study]9.7854393
GSM549134patient 033, cancer, homogenized [OPG study]9.5642292
GSM549136patient 036, cancer, homogenized [OPG study]9.7394293
GSM549140patient 044, cancer, homogenized [OPG study]10.027694
GSM549111patient 047, normal, homogenized [OPG study]9.4547791
GSM549113patient 057, normal, homogenized [OPG study]9.548791
GSM549132patient 031, cancer, homogenized [OPG study]9.7924593
GSM549137patient 038, cancer, homogenized [OPG study]10.063595
GSM549142patient 047, cancer, homogenized [OPG study]9.0045192
GSM549100patient 110, normal, homogenized [OPG study]9.3004191
GSM549107patient 135, normal, homogenized [OPG study]9.4255291
GSM549115patient 068, normal, homogenized [OPG study]9.595691
GSM549116patient 072, normal, homogenized [OPG study]9.6643892
GSM549120patient 078, normal, homogenized [OPG study]9.3576991
GSM549131patient 030, cancer, homogenized [OPG study]9.222490
GSM549118patient 074, normal, homogenized [OPG study]9.0555489
GSM549129patient 027, cancer, homogenized [OPG study]9.745994
GSM549123patient 088, normal, homogenized [OPG study]9.3920491
GSM549124patient 006, cancer, homogenized [OPG study]9.038390
GSM549126patient 015, cancer, homogenized [OPG study]9.5382592
GSM549128patient 025, cancer, homogenized [OPG study]9.488792
GSM549103patient 117, normal, homogenized [OPG study]9.2186991
GSM549117patient 073, normal, homogenized [OPG study]9.5191691
GSM549138patient 041, cancer, homogenized [OPG study]9.2202990
GSM549141patient 045, cancer, homogenized [OPG study]9.7879493
GSM549130patient 028, cancer, homogenized [OPG study]9.3285391
GSM549101patient 111, normal, homogenized [OPG study]9.6319593
GSM549105patient 128, normal, homogenized [OPG study]9.4212291
GSM549106patient 134, normal, homogenized [OPG study]10.083894
GSM549112patient 048, normal, homogenized [OPG study]9.5630492
GSM549125patient 011, cancer, homogenized [OPG study]9.4658392
GSM549127patient 024, cancer, homogenized [OPG study]9.6052493
GSM549135patient 035, cancer, homogenized [OPG study]9.0150188